Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsSummaCare Part D Transition Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentSummaCarePolicy H3660_SC2836_C

    2027 SummaCare Medicare Part D Transition Process

    Customize your policy alerts

    Sign up for summacare Policy H3660_SC2836_C alerts

    Get alerted when Policy H3660_SC2836_C changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy explains how SummaCare Medicare Part D members can receive temporary supplies of nonformulary drugs or drugs subject to prior authorization, step therapy, or quantity limits. It also governs formulary exception requests, physician documentation, decision timeframes, and appeals for eligible new, continuing, and long-term care members.

    Policy Summary
    PayerSummaCare
    Policy2027 SummaCare Medicare Part D Transition Process
    Policy CodePolicy H3660_SC2836_C
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit the required medical-necessity statement through MedImpact when requesting a formulary exception.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    90 daysRetail or mail-order transition period
    1 monthMinimum temporary supply
    72 hoursStandard exception decision
    24 hoursExpedited exception decision

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    65 days
    Appeal request deadline

    Transition and Exception Coverage Criteria

    Transition eligibility

    Members eligible for the transition process include at least one of the following categories:

    Eligible member categories

    • The member is a new enrollee into a prescription drug plan following the annual coordinated election period.
    • The member is a newly eligible Medicare beneficiary transitioning from other coverage.
    • The member switched from one plan to another after the start of the contract year.
    • The member is a current enrollee affected by a negative formulary change across contract years.
    • The member resides in a long-term care facility.

    Retail or mail-order transition supply

    For a retail or mail-order transition supply, all of the following conditions apply:

    Retail or mail-order temporary fill

    • The prescription drug is not on the Formulary, or the member's ability to obtain the drug is limited by a Prior Authorization, Step Therapy, or Quantity Limit requirement.
    • The fill occurs during the first 90 days of the member's enrollment with SummaCare Medicare.First 90 days of enrollment
    • The prescription is filled at a network pharmacy.
    • The plan provides at least one temporary fill of at least a month's supply.At least one temporary fill; at least a month's supply

    Long-term care transition supply

    For a member residing in a long-term care facility, all of the following conditions apply:

    Long-term care transition fill

    • The member resides in a long-term care facility.
    • The member needs a prescription drug that is not on the Formulary or whose access is limited by coverage requirements or limits.
    • The plan provides at least one temporary fill of at least a month's supply.At least one temporary fill; at least a month's supply
    • If the prescription is written for fewer days, multiple fills may be used to provide at least a month's supply.
    • If the member is past the first 90 days of SummaCare Medicare membership, the plan provides at least one temporary fill of at least a month's emergency supply while the member pursues a Formulary Exception.

    Level-of-care change

    A transition supply is available when all of the following conditions apply:

    Level-of-care transition

    • The member is a current SummaCare Medicare member who experiences a change in level of care from one treatment setting to another.
    • The prescription drug is not on the Formulary, or is on the Formulary but subject to coverage requirements or limits.
    • For a current long-term care enrollee entering a facility from another care setting, the plan provides at least one temporary fill of at least a month's supply.At least one temporary fill; at least a month's supply

    Formulary exception criteria

    A Formulary Exception may be requested when at least one of the following medical-necessity grounds applies:

    Exception grounds

    • The prescribing physician determines that none of the drugs covered for the member's condition would be as effective as the requested drug.
    • A drug covered for the member's condition would cause adverse effects for the member.
    • A Prior Authorization, Quantity Limit, or other coverage limit is not medically appropriate given the member's condition or would cause adverse effects for the member.

    After the one-time temporary supply is provided, SummaCare will not continue payment for a nonformulary drug or a drug subject to coverage limits, even if the member has been enrolled for less than 90 days, unless a formulary exception has been granted.

    Requests, Documentation, and Transition Rules

    Prior Authorization

    Prior Authorization Transition and Exception

    When a drug is not on the formulary or is subject to Prior Authorization (PA), Quantity Limit (QL), or another restriction, the member or prescribing physician may request an exception. SummaCare provides at least one temporary fill of at least a month's supply during the first 90 days of enrollment at a network pharmacy while the exception or an alternative is pursued.

    • Submit the exception request: The prescribing physician should contact MedImpact at 877.391.1109 (TTY 711), by mail at MedImpact Healthcare Systems, Inc., 10181 Scripps Gateway Court, San Diego, CA 92131, by fax at 858.790.7100, or through the Coverage Determination Request Form at summacare.com/medicare-members.
    • A PA, QL, or other limit may be excepted when the physician states that the restriction is not medically appropriate for the member's condition or would cause adverse effects.
    Step Therapy

    Step Therapy Transition and Exception

    If a drug is subject to Step Therapy (ST) or is not covered, first ask whether SummaCare covers another drug for the member's condition and discuss that option with the physician. If the physician determines that the covered alternatives are not medically appropriate, submit a formulary exception request.

    Key Terms

    Formulary
    DefinitionThe list of drugs covered by SummaCare Medicare.
    Coverage statusA drug may be absent from the Formulary or may be removed from the Formulary across contract years.
    Member actionIf a drug is not on the Formulary, the member may work with the health care provider to switch to a therapeutically equivalent Formulary drug or request a Formulary exception.
    Prior Authorization (PA)
    DefinitionA requirement that must be satisfied before coverage of a drug is provided.
    When it appliesA Formulary drug may be subject to Prior Authorization, which limits the member's ability to obtain the drug until the requirement is addressed.

    Initial Transition Supply

    Initial transition supply

    Initial transition coverage is available when all of the following conditions apply:

    • The member needs a prescription drug that is not on the Formulary or is subject to Prior Authorization, Step Therapy, or Quantity Limit restrictions.
    • The applicable enrollment, long-term care, or level-of-care transition requirements are met.
    • The prescription is dispensed through the required pharmacy arrangement: a network pharmacy for retail or mail-order fills, or the long-term care pharmacy for long-term care residents.
    • The plan provides at least one temporary fill of at least a month's supply, subject to the applicable retail, long-term care, or level-of-care rules.At least one month's supply; first 90 days for retail or mail-order fills

    Coverage After the Transition Supply

    Continuation after transition supply

    Continued coverage after a transition supply requires at least one of the following circumstances:

    Continuation circumstances

    • A Formulary Exception has been granted.
    • The member is a long-term care resident past the first 90 days of SummaCare Medicare membership and is receiving the one-time emergency supply while pursuing a Formulary Exception.After day 90; one-time emergency supply
    • The member is undergoing a qualifying change in level of care and receives the applicable transition supply.

    Step Therapy Exception Path

    Step therapy pathwayAction
    Another covered drug may be availableAsk SummaCare whether another covered drug is available to treat your medical condition.
    Physician reviewAsk your physician whether the covered drug is an appropriate treatment option for you.
    Exception requestIf your physician determines that covered drugs are not medically appropriate, you may request an exception.

    Where Transition Supplies Are Dispensed

    Billing Rule

    Use a network pharmacy

    For a retail or mail-order transition supply, the prescription must be filled at a network pharmacy.

    Billing Rule

    Dispense transition supplies through the long-term care pharmacy

    Long-term care residents receive transition supplies through the long-term care pharmacy. The pharmacy may provide the drug in smaller amounts at a time to prevent waste; multiple fills may be used when the prescription is written for fewer days.

    Policy Summary
    PayerSummaCare
    Policy2027 SummaCare Medicare Part D Transition Process
    Policy CodePolicy H3660_SC2836_C
    Change TypeNo material change
    Effective DateN/A
    Next Review DateN/A
    Key ActionSubmit the required medical-necessity statement through MedImpact when requesting a formulary exception.
    SourceLink
    On This Page
    Transition and Exception Coverage CriteriaRequests, Documentation, and Transition RulesKey TermsInitial Transition SupplyCoverage After the Transition SupplyStep Therapy Exception PathWhere Transition Supplies Are Dispensed
    If the prescription is written for fewer days, multiple fills may be used to provide at least a month's supply.
    After day 90: at least one temporary fill of at least a month's emergency supply
    • Ask about an alternative covered drug used to treat the condition.
    • Submit an exception request when none of the covered alternatives would be medically appropriate for the member.
    Documentation Required

    Required Physician Statement

    The prescribing physician must provide supporting documentation with the exception request. The statement must explain why the requested drug is medically necessary for the member's condition and why covered alternatives would not be as effective or would cause adverse effects.

    • For an exception involving PA, QL, or another plan limit, state why the limit is not appropriate given the member's condition or would cause adverse effects.
    • Standard requests are decided within 72 hours after the physician's statement is submitted; expedited requests are decided within 24 hours when waiting could seriously jeopardize the member's life, health, or ability to regain maximum function.
    Denial Risk

    No Continued Payment Without an Exception

    After SummaCare covers the temporary transition supply, it will not continue paying for the drug—even if the member has been enrolled for fewer than 90 days—unless an exception has been granted.

    • The temporary supply is at least a one-time fill of at least a month's supply during the first 90 days of enrollment.
    • The prescription must be filled at a network pharmacy; multiple fills may be allowed when the prescription is written for fewer days.
    Denial Risk

    Insufficient Medical-Necessity Support

    An exception request is at risk of denial if the prescribing physician does not submit the required information supporting medical necessity. The documentation must address the member's condition, the inadequacy or adverse effects of covered alternatives, and, when applicable, why the PA, QL, or other restriction is inappropriate.

    • Provide supporting documentation with every exception request.
    • The physician's statement must specifically support why the requested drug is medically necessary; a request lacking this information may not establish eligibility for the exception.
    Exception optionThe member or prescribing physician may request an exception when the Prior Authorization requirement is not medically appropriate for the member's condition or would cause adverse effects.
    Step Therapy (ST)
    DefinitionA requirement to try or use another covered drug before coverage of the requested drug.
    Alternative reviewThe member may ask whether another covered drug can treat the medical condition and may discuss that option with the physician.
    Exception optionAn exception may be requested when the physician determines that covered alternatives are not medically appropriate, would not be as effective, or would cause adverse effects.
    Quantity Limit (QL)
    DefinitionA limit on the amount or use of a drug that SummaCare will cover.
    When it appliesA Formulary drug may be covered subject to a Quantity Limit that restricts the member's access to the drug.
    Exception optionAn exception may be requested when the Quantity Limit is not medically appropriate for the member's condition or would cause adverse effects.
    Transition Process
    DefinitionA process that temporarily provides access to a nonformulary drug or a Formulary drug subject to coverage restrictions while the member works with the provider to change therapy or request a Formulary exception.
    Temporary accessEligible members may receive at least a one-time temporary supply of at least a month's supply under the applicable retail, mail-order, long-term care, or level-of-care rules.
    PurposeThe process gives the member time to work with the health care provider to switch to a therapeutically equivalent Formulary drug or complete the Formulary Exceptions process.